Jacob Gopas
Beersheba, D 84105, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
In Vitro Modelling of Obstructive Sleep Apnea by Intermittent Hypoxia of Human Embryonic Stem Cell-Derived Cardiomyocytes: Expression of ERK1/2, ERK5 and Erbin.
Journal: International journal of molecular sciences
Published: June 19, 2026
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells.
Journal: Hematology, transfusion and cell therapy
Published: February 23, 2025
Nebivolol, an FDA-Approved Drug, Has General Antibacterial and Antibiofilm Effects and Increases Pseudomonas aeruginosa Tolerance to Ciprofloxacin.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 22, 2024
NF-κB Inhibitory Activity of the Di-Hydroxy Derivative of Piperlongumine (PL-18).
Journal: Journal of immunology research
Published: September 10, 2024
Anti-Leishmania major Properties of Nuphar lutea (Yellow Water Lily) Leaf Extracts and Purified 6,6' Dihydroxythiobinupharidine (DTBN).
Journal: Pathogens (Basel, Switzerland)
Published: March 25, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney disease.
Journal: Scientific reports
Published: November 03, 2023
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells.
Journal: Translational oncology
Published: September 21, 2023
In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2.
Journal: International journal of molecular sciences
Published: March 21, 2023
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
Journal: International journal of molecular sciences
Published: February 24, 2023
Editorial: Development of novel small molecules as therapeutics for inflammatory diseases and delineating their molecular mechanisms.
Journal: Frontiers in pharmacology
Published: November 03, 2022
Obstructive Sleep Apnea Syndrome In Vitro Model: Controlled Intermittent Hypoxia Stimulation of Human Stem Cells-Derived Cardiomyocytes.
Journal: International journal of molecular sciences
Published: July 24, 2022
Last Updated: 09/26/2026